---
title: 'F096 Why can we be optimistic about the vaccine development for COVID-19? (Glen de Vries, Medidata)'
type: 'episode'
url: 'https://doc.social/episodes/f096-why-can-we-be-optimistic-about-the-vaccine-development-for-covid-19-glen-de-vries-medidata'
show: 'Faces of Digital Health'
show_url: 'https://doc.social/podcasts/faces-of-digital-health'
published: '2020-08-28'
audio: 'https://traffic.megaphone.fm/DHT6897474892.mp3'
---

# F096 Why can we be optimistic about the vaccine development for COVID-19? (Glen de Vries, Medidata)

Glen de Vries is president of Medidata, the world’s largest platform for clinical research trial data. Medidata is working with several research groups working on the COVID-19 vaccine, including messenger RNA based vaccines in development by Moderna, whi...

## Summary

Why are clinical trials complicated and how is technology from platforms to AI helping accelerate trial development and data analysis.